8-K: Venus Concept Exceeds Revenue Estimates Despite Overall Decline in First Quarter 2024

Venus Concept reported a 15% year-over-year revenue decrease to $17.5 million for the first quarter of 2024, but exceeded its own estimate by $1 million.

Summary

• Venus Concept's total revenue for the first quarter of 2024 was $17.5 million, a 15% decrease compared to $20.5 million in the same period last year.
• The company exceeded its first quarter revenue estimate of at least $16.5 million by 6%, or $1.0 million.
• Cash used in operations decreased by 51% year-over-year, from $5.9 million to $2.9 million.
• Cash system revenue represented approximately 75% of total systems and subscriptions revenue, compared to 66% in the prior year period.
• The company's operating loss was $7.8 million, compared to $8.2 million in the first quarter of 2023.
• Net loss attributable to stockholders was $9.8 million, or $1.68 per share, compared to a net loss of $9.7 million, or $1.84 per share, in the first quarter of 2023.
• Adjusted EBITDA loss for the first quarter of 2024 was $5.1 million, compared to $5.7 million for the same period last year.
• The company had $5.1 million in cash and cash equivalents and $76.7 million in total debt obligations as of March 31, 2024.
• The company expects total revenue for the three months ending June 30, 2024, to be at least $16.5 million.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to exceeding revenue estimates and improving cash flow, but tempered by the overall revenue decline, net loss, and significant debt. The restructuring efforts and new financing are positive signs, but the company still faces challenges.

Positives

• The company exceeded its revenue estimates for the first quarter of 2024.
• Cash used in operations significantly decreased year-over-year.
• The shift towards cash sales is progressing, with cash system revenue increasing as a percentage of total revenue.
• The company secured additional debt financing to support near-term liquidity.
• The company received regulatory approvals for key products in Australia and Israel.
• Operating expenses were reduced by 11% year-over-year.
• The adjusted EBITDA loss improved compared to the same period last year.

Negatives

• Total revenue decreased by 15% year-over-year.
• Revenue decreased in both the United States and international markets.
• Subscription system revenue decreased by 38.7% year-over-year.
• Gross profit decreased by 15% year-over-year.
• The company reported a net loss of $9.8 million for the quarter.
• The company has a significant debt load of $76.7 million.

Risks

• The company is facing macroeconomic headwinds that are impacting aesthetic capital equipment sales.
• Strategic initiatives are impacting revenue outside the U.S.
• The company is still experiencing a significant operating loss.
• The company has a substantial debt burden.
• The company is not providing full-year 2024 financial guidance due to ongoing strategic evaluations.
• The company is facing a challenge from the Canada Revenue Agency regarding denied wage subsidy claims.

Future Outlook

The company expects total revenue for the three months ending June 30, 2024, to be at least $16.5 million. They are not providing full year 2024 guidance due to ongoing strategic evaluations.

Management Comments

• First quarter revenue results exceeded the expectations we outlined on our fourth quarter report, said Rajiv De Silva, Chief Executive Officer of Venus Concept.
• Aesthetic capital equipment sales continue to be challenged by macroeconomic headwinds and our revenue results outside the U.S. continue to be impacted by the strategic initiatives we initiated last year.
• Importantly, our efforts to reposition the business and transition the Company to higher quality cash revenues, exiting unprofitable direct operations in international markets and other restructuring activities, are proving effective.
• We are enhancing our cash flow profile and accelerating the path to long-term, sustainable, profitability and growth.
• We recently announced the completion of the first phase of our restructuring efforts with Madryns purchase of our outstanding senior debt facility and extension of bridge financing.
• We appreciate Madryns ongoing support of the Company as we work towards cash flow breakeven and sustainable profitability.
• As the Company continues implementing its turnaround plans, debt restructuring and financing remain important near-term priorities to catalyze our growth plans.

Industry Context

The medical aesthetics industry is facing macroeconomic challenges, impacting capital equipment sales. Venus Concept's restructuring efforts and focus on cash sales reflect a broader trend in the industry to improve financial stability and profitability. Competitors in the aesthetic device market are likely facing similar pressures, making Venus Concept's strategic shift a necessary move to remain competitive.

Comparison to Industry Standards

• While specific competitor results are not provided in this document, Venus Concept's 15% revenue decline is significant and suggests they are facing challenges in line with the broader industry headwinds.
• The shift to cash sales is a positive move, as many companies in the medical device sector are moving away from subscription models to improve cash flow.
• The reduction in operating expenses by 11% is a positive sign, as many companies are looking to reduce costs in the current economic climate.
• The adjusted EBITDA loss of $5.1 million is still significant, and the company needs to continue to improve profitability to be competitive with industry leaders such as Cutera, Cynosure, and InMode, who have demonstrated stronger financial performance.
• The debt load of $76.7 million is a concern, and the company will need to manage this carefully to avoid financial distress. Companies with lower debt levels, such as InMode, are generally viewed more favorably by investors.

Legal Proceedings

• The company is disputing a Canada Revenue Agency assessment regarding denied Canada Emergency Wage Subsidy claims and intends to challenge this matter through the Tax Court or Judicial Review.

Stakeholder Impact

• Shareholders may be concerned about the revenue decline and net loss, but encouraged by the improved cash flow and restructuring efforts.
• Employees may be affected by the restructuring activities.
• Customers may see improvements in product availability and service as the company focuses on cash sales.
• Suppliers may be impacted by the company's restructuring and cost-cutting measures.
• Creditors may be concerned about the company's debt load but reassured by the new financing.

Next Steps

• The company will continue to implement its turnaround plans.
• The company will focus on debt restructuring and financing.
• The company will continue to evaluate strategic alternatives to maximize shareholder value.
• The company will provide updates on its progress.

Key Dates

Keywords

Venus Concept, medical aesthetics, financial results, revenue, EBITDA, debt financing, restructuring, regulatory approvals, cash flow, operating expenses